Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis

Hepatology International

Volumn 7, Issue 2, 2013, Pages 767-774

  Koga, Hironori ^a   Tamiya, Yoshitaka ^a   Mitsuyama, Keiichi ^a   Ishibashi, Masahiko ^b   Matsumoto, Satoshi ^c   Imaoka, Akemi ^c   Hara, Taeko ^c   Nakano, Masatoshi ^c   Ooeda, Kazutoshi ^c   Umezaki, Yoshinori ^c   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Orin Hospital   (Japan)

^c YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Lactobacillus; Randomized placebo controlled study; Real time quantitative PCR (qPCR); Transthyretin

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PLACEBO; PREALBUMIN; PROBIOTIC AGENT; TRANSFERRIN;

ABSENCE OF SIDE EFFECTS; ADULT; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ANAEROBIC BACTERIUM; ARTICLE; BACTEROIDES FRAGILIS; BEVERAGE; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM LEPTUM; COHORT ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENTEROBACTERIACEAE; EUBACTERIUM; EUBACTERIUM CYLINDROIDES; FECES MICROFLORA; FEMALE; HUMAN; INTESTINE FLORA; LACTOBACILLUS CASEI; LIVER FUNCTION; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; TRANSFERRIN BLOOD LEVEL;

EID: 84879836995     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-012-9408-x     Document Type: Article

References (41)

1. Jaeschke H, Gores GJ, Cederbaum AI, et al. Mechanisms of hepatotoxicity. Toxicol Sci. 2002;65:166-176
2. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology. 2003;124:778-790
3. Enomoto N, Ikejima K, Bradford B, et al. Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology. 1998;115:443-451
4. Bautista AP. Neutrophilic infiltration in alcoholic hepatitis. Alcohol. 2002;27:17-21
5. Saleh M, Elson CO. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity. 2011;34:293-302
6. Rockey DC. Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis. 2006;10:459-479
7. Sakisaka S, Koga H, Sasatomi K, Mimura Y, Kawaguchi T, Tanikawa K. Biliary secretion of endotoxin and pathogenesis of primary biliary cirrhosis. Yale J Biol Med. 1997;70:403-408
8. Ma TY, Nguyen D, Bui V, Nguyen H, Hoa N. Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol. 1999;276:G965-G974
9. Cesaro C, Tiso A, Del Prete A, et al. Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis. 2011;43:431-438
10. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology. 1995;108:218-224
11. Liu Q, Duan ZP, Ha DK, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441-1449
12. Stadlbauer V, Mookerjee RP, Hodges S, et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol. 2008;48:945-951
13. Rayes N, Seehofer D, Hansen S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74:123-127
14. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004;70:7220-7228
15. Matsuki T. Development of quantitative PCR detection method with 16S rRNA gene-targeted genus- and species-specific primers for the analysis of human intestinal microflora and its application. Nihon Saikingaku Zasshi. 2007;62:255-261
16. Tana C, Umesaki Y, Imaoka A, et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:512-519
17. Kurakawa T, Kubota H, Tsuji H, et al. Development of a sensitive rRNA-targeted reverse transcription-quantitative polymerase chain reaction for detection of Vibrio cholerae/mimicus, V. parahaemolyticus/alginolyticus and Campylobacter jejuni/coli. Microbiol Immunol. 2012;56:10-20
18. Morishita T, Fukada T, Shirota M, Yura T. Genetic basis of nutritional requirements in Lactobacillus casei. J Bacteriol. 1974;120:1078-1084
19. Nanno M, Kato I, Kobayashi T, Shida K. Biological effects of probiotics: what impact does Lactobacillus casei Shirota have on us? Int J Immunopathol Pharmacol. 2011;24(Suppl 1):45S-50S
20. Nagata S, Asahara T, Ohta T, et al. Effect of the continuous intake of probiotic-fermented milk containing Lactobacillus casei strain Shirota on fever in a mass outbreak of norovirus gastroenteritis and the faecal microflora in a health service facility for the aged. Br J Nutr. 2011;106:549-556
21. Tuohy KM, Pinart-Gilberga M, Jones M, et al. Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. J Appl Microbiol. 2007;102:1026-1032
22. Matsumoto S, Hara T, Hori T, et al. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol. 2005;140:417-426
23. Matsumoto S, Hara T, Nagaoka M, et al. A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer. Immunology. 2009;128:e170-e180
24. Mookerjee RP, Stadlbauer V, Lidder S, et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology. 2007;46:831-840
25. Fujimoto J, Matsuki T, Sasamoto M, Tomii Y, Watanabe K. Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. Int J Food Microbiol. 2008;126:210-215
26. Matsumoto K, Takada T, Shimizu K, et al. The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci Microflora. 2006;25:39-48
27. Matsuda K, Tsuji H, Asahara T, et al. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription- quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol. 2009;75:1961-1969
28. Caregaro L, Alberino F, Amodio P, et al. Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr. 1996;63:602-609
29. Chang WT, Ker CG, Hung HC, et al. Albumin and prealbumin may predict retinol status in patients with liver cirrhosis. Hepatogastroenterology. 2008;55:1681-1685
30. Goodman DS. Retinol-binding protein, prealbumin, and vitamin A transport. Prog Clin Biol Res. 1976;5:313-330
31. Yamamoto Y, Yoshizawa T, Kamio S, et al. Interactions of transthyretin (TTR) and retinol-binding protein (RBP) in the uptake of retinol by primary rat hepatocytes. Exp Cell Res. 1997;234:373-378
32. Monaco HL. The transthyretin-retinol-binding protein complex. Biochim Biophys Acta. 2000;1482:65-72
33. Hendriks HF, Verhoofstad WA, Brouwer A, de Leeuw AM, Knook DL. Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver. Exp Cell Res. 1985;160:138-149
34. Blomhoff R, Berg T, Norum KR. Distribution of retinol in rat liver cells: effects of age, sex and nutritional status. Br J Nutr. 1988;60:233-239
35. Vogel S, Piantedosi R, Frank J, et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res. 2000;41:882-893
36. Vicente CP, Fortuna VA, Margis R, Trugo L, Borojevic R. Retinol uptake and metabolism, and cellular retinol binding protein expression in an in vitro model of hepatic stellate cells. Mol Cell Biochem. 1998;187:11-21
37. Nishikawa T, Hagihara K, Serada S, et al. Transcriptional complex formation of c-Fos, STAT3, and hepatocyte NF-1 alpha is essential for cytokine-driven C-reactive protein gene expression. J Immunol. 2008;180:3492-3501
38. Horiguchi N, Wang L, Mukhopadhyay P, et al. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology. 2008;134:1148-1158
39. Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461-2463
40. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006;108:3204-3209
41. Bugaut M. Occurrence, absorption and metabolism of short chain fatty acids in the digestive tract of mammals. Comp Biochem Physiol B. 1987;86:439-472